146 related articles for article (PubMed ID: 20859678)
1. Effects of estrogen on the proportion of stem cells in the breast.
Simões BM; Piva M; Iriondo O; Comaills V; López-Ruiz JA; Zabalza I; Mieza JA; Acinas O; Vivanco MD
Breast Cancer Res Treat; 2011 Aug; 129(1):23-35. PubMed ID: 20859678
[TBL] [Abstract][Full Text] [Related]
2. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
[TBL] [Abstract][Full Text] [Related]
3. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
4. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
Tulsyan S; Agarwal G; Lal P; Mittal B
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
[TBL] [Abstract][Full Text] [Related]
5. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
6. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
7. A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors.
Rahmatpanah FB; Jia Z; Chen X; Char JE; Men B; Franke AC; Jones FE; McClelland M; Mercola D
Oncotarget; 2015 Jan; 6(2):1286-301. PubMed ID: 25428913
[TBL] [Abstract][Full Text] [Related]
8. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
9. Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
[TBL] [Abstract][Full Text] [Related]
10. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract][Full Text] [Related]
11. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.
Simões BM; Vivanco MD
Future Oncol; 2011 Aug; 7(8):995-1006. PubMed ID: 21823894
[TBL] [Abstract][Full Text] [Related]
13. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2.
Pierantozzi E; Gava B; Manini I; Roviello F; Marotta G; Chiavarelli M; Sorrentino V
Stem Cells Dev; 2011 May; 20(5):915-23. PubMed ID: 20879854
[TBL] [Abstract][Full Text] [Related]
14. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines.
Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Takakura Y
Int J Oncol; 2009 May; 34(5):1381-6. PubMed ID: 19360350
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of NANOG and KLF4 for breast cancer.
Nagata T; Shimada Y; Sekine S; Hori R; Matsui K; Okumura T; Sawada S; Fukuoka J; Tsukada K
Breast Cancer; 2014 Jan; 21(1):96-101. PubMed ID: 22528804
[TBL] [Abstract][Full Text] [Related]
17. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.
Wang Y; Xu Z; Jiang J; Xu C; Kang J; Xiao L; Wu M; Xiong J; Guo X; Liu H
Dev Cell; 2013 Apr; 25(1):69-80. PubMed ID: 23541921
[TBL] [Abstract][Full Text] [Related]
18. [Analysis on the expression of the stem cells related genes in hepatocellular carcinoma cell lines].
Zou C; Yuan FJ; Zhou WB; Huang L; Wang J; Zhang YS
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):599-602. PubMed ID: 19719918
[TBL] [Abstract][Full Text] [Related]
19. Role of SOX2 in maintaining pluripotency of human embryonic stem cells.
Adachi K; Suemori H; Yasuda SY; Nakatsuji N; Kawase E
Genes Cells; 2010 May; 15(5):455-70. PubMed ID: 20384793
[TBL] [Abstract][Full Text] [Related]
20. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
Fong H; Hohenstein KA; Donovan PJ
Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
